3 most recent filings and news items mentioning LPCN. Updated every 60 seconds.
curl "https://api.brieftape.com/v1/tickers/LPCN/news?limit=20"
Pull LPCN filings straight into your trading bot, model, or app.
Get an API key — free tier: 10,000 calls/dayLipocine will host a virtual event on June 12, 2026 featuring key opinion leaders discussing unmet needs in postpartum depression and the clinical profile of its investigational oral brexanolone LPCN 1154. The company will present Phase 3 topline results and discuss potential mar
View filing at SEC.gov →Lipocine Inc. submitted exhibit 99.1 as part of an 8-K filing with the Securities and Exchange Commission. The filing indicates a corporate disclosure or announcement requiring investor notification.
View filing at SEC.gov →Lipocine announced that Phase 3 clinical data for LPCN 1154, an oral brexanolone candidate for postpartum depression, was accepted for oral and poster presentations at the American Society of Clinical Psychopharmacology Annual Meeting in May 2026. The presentation will showcase r
View filing at SEC.gov →